GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tibet Rhodiola Pharmaceutical Holding Co (SHSE:600211) » Definitions » Total Long-Term Liabilities

Tibet Rhodiola Pharmaceutical Holding Co (SHSE:600211) Total Long-Term Liabilities : ¥33 Mil (As of Mar. 2025)


View and export this data going back to 1999. Start your Free Trial

What is Tibet Rhodiola Pharmaceutical Holding Co Total Long-Term Liabilities?

Total Long-Term Liabilities includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities. Tibet Rhodiola Pharmaceutical Holding Co's Total Long-Term Liabilities for the quarter that ended in Mar. 2025 was ¥33 Mil.

Tibet Rhodiola Pharmaceutical Holding Co Total Long-Term Liabilities Historical Data

The historical data trend for Tibet Rhodiola Pharmaceutical Holding Co's Total Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tibet Rhodiola Pharmaceutical Holding Co Total Long-Term Liabilities Chart

Tibet Rhodiola Pharmaceutical Holding Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Total Long-Term Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 24.80 47.97 42.69 29.27 28.66

Tibet Rhodiola Pharmaceutical Holding Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Total Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 30.28 31.72 30.93 28.66 33.07

Tibet Rhodiola Pharmaceutical Holding Co Total Long-Term Liabilities Calculation

Total Long-Term Liabilities represents the obiligation that incurred as part of normal operations that is expected to be repaid beyond the following twelve months or one business cycle, excluding minority interest. It includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities.

Tibet Rhodiola Pharmaceutical Holding Co Total Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Tibet Rhodiola Pharmaceutical Holding Co's Total Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Tibet Rhodiola Pharmaceutical Holding Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tibet Rhodiola Pharmaceutical Holding Co (SHSE:600211) » Definitions » Total Long-Term Liabilities
Comparable Companies
SZSE:002020 SZSE:002317 SZSE:300026 SHSE:600572 SZSE:300119 SHSE:600129 SZSE:301263 SZSE:002675 SHSE:600422 SHSE:600993 ZTS XTER:MRK LSE:HLN NSE:SUNPHARMA TSE:4502 XSWX:GALD XSWX:SDZ NSE:DIVISLAB HKSE:03692 XTAE:TEVA
Traded in Other Exchanges
N/A
Address
No. 93, Beijing Middle Road, Tibet Autonomous Region, Lhasa, CHN, 610023
Website
http://www.xzyy.cn
Tibet Rhodiola Pharmaceutical Holding Co is a Chinese company producing biological products and traditional Tibetan medicines.
Executives
Wang Bao Ming senior management
Peng Hui Director
Cao Shu Zhen senior management
Si Qin Director
Ren Bei Chen Supervisors
Liu De Gong Supervisors
Gao Zi Li senior management
Zhou Ming De senior management
Chen Li Ye senior management
Lin Ben Director
Chen Da Bin Director

Tibet Rhodiola Pharmaceutical Holding Co Headlines

No Headlines